Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1642220

	registered interest
	date	06/06/2023
	answering body	Department for Business and Trade
	answering dept id	214
	answering dept short name	Business and Trade
	answering dept sort name	Business and Trade
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business and Trade, what assessment she has made of the impact of exporting medical cannabis on the UK economy; and if she will make a statement.
	tabling member constituency	North Herefordshire
	tabling member printed	Sir Bill Wiggin
	uin	187910
	answer	answer is ministerial correction date of answer 16/06/2023 answer text <p>Life Sciences is one the UK’s top exporting sectors, with exports valued at £28.1 billion in 2022. No assessment has currently been made by the department of the impact of exporting medicinal cannabis on the UK economy. The department supports UK manufacturers of medical cannabis who have obtained a controlled drug licence from the Home Office and relevant licences from MHRA; and where the use of medicinal cannabis is both (a) legal in the destination market and (b) only for medical or scientific purposes. <br></p> answering member constituency Mid Worcestershire answering member printed Nigel Huddleston question first answered 16/06/2023 13:12:20 answering member 4407 label Biography information for Nigel Huddleston
	tabling member	1428 label Biography information for Sir Bill Wiggin

1642221

	registered interest
	date	06/06/2023
	answering body	Department for Business and Trade
	answering dept id	214
	answering dept short name	Business and Trade
	answering dept sort name	Business and Trade
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business and Trade, what assessment her Department has made of the growth potential for the cannabinoid-based medicines industry; and if she will make a statement.
	tabling member constituency	North Herefordshire
	tabling member printed	Sir Bill Wiggin
	uin	187911
	answer	answer is ministerial correction date of answer 16/06/2023 answer text <p>No assessment has been made on the growth potential for the cannabinoid-based medicine industry which also creates opportunities for the agri-tech sector. The department will continue to deliver against the priority sub-sectors outlined in the Life Science Vision, through our role in pursuing and landing inward investment, enabling exports, attracting global talent and capital, and leading on trade policy and defending free trade.</p> answering member constituency Mid Worcestershire answering member printed Nigel Huddleston question first answered 16/06/2023 13:18:11 answering member 4407 label Biography information for Nigel Huddleston
	tabling member	1428 label Biography information for Sir Bill Wiggin

1642222

	registered interest
	date	06/06/2023
	answering body	Department for Business and Trade
	answering dept id	214
	answering dept short name	Business and Trade
	answering dept sort name	Business and Trade
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business and Trade, if she will commission research into the potential benefits to the economy of cannabinoid-based products for medicinal use; and if she will make a statement.
	tabling member constituency	North Herefordshire
	tabling member printed	Sir Bill Wiggin
	uin	187912
	answer	answer is ministerial correction date of answer 16/06/2023 answer text <p>The department has no plans to assess the impact of the medical cannabis industry on the economy. Data is annually published on the impact on the economy and employment of the wider Life Sciences sector in the <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fcollections%2Fbioscience-and-health-technology-database-annual-reports&amp;data=05%7C01%7CRobert.Reid%40officeforlifesciences.gov.uk%7C52a0f4af72164a3b141608da90ba3996%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637981426767702174%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=xG98g%2B1%2BBzW72DAM8Cpp8i%2FEn2ic5G1qf2ZbOzZsXXU%3D&amp;reserved=0" target="_blank">Bioscience and health technology sector statistics</a>. This includes analysis of the bio-pharmaceuticals sector of which the medical cannabis industry is a subsector.</p> answering member constituency Mid Worcestershire answering member printed Nigel Huddleston question first answered 16/06/2023 13:20:04 answering member 4407 label Biography information for Nigel Huddleston
	tabling member	1428 label Biography information for Sir Bill Wiggin

1681904

	registered interest
	date	15/01/2024
	answering body	Department for Business and Trade
	answering dept id	214
	answering dept short name	Business and Trade
	answering dept sort name	Business and Trade
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State of Business and Trade, what estimate she has made of the contribution of domestic medicinal cannabis production to the economy.
	tabling member constituency	Romford
	tabling member printed	Andrew Rosindell
	uin	9454
	answer	answer is ministerial correction date of answer 23/01/2024 answer text <p>The Department for Business and Trade (DBT) actively assists life sciences companies in their endeavours to invest, expand, and export, thereby generating employment and economic growth.</p><p>UK-based life sciences businesses receive support from DBT through trade missions to key markets, participation in major trade events, tackling market access barriers, upskilling exporters, and guidance on entering new markets. Although routine assessments of the economic impact of specific life sciences’ subsectors like medicinal cannabis are not conducted, DBT is committed to supporting companies of various sizes throughout their export and inward investment endeavours while adhering to national regulatory guidelines.</p> answering member constituency Thirsk and Malton answering member printed Kevin Hollinrake question first answered 23/01/2024 17:59:05 answering member 4474 label Biography information for Kevin Hollinrake
	tabling member	1447 label Biography information for Andrew Rosindell

1503897

	registered interest
	date	02/09/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, if his Department will make an assessment of the impact of the medical cannabis industry on (a) the economy and (b) employment levels.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	45558
	answer	answer is ministerial correction date of answer 28/09/2022 answer text <p>The Department has no plans to make an assessment of the impact of the medical cannabis industry on the economy or employment levels. The Department annually publishes data on the impact on the economy and employment of the wider Life Sciences sector in the <a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.gov.uk%2Fgovernment%2Fcollections%2Fbioscience-and-health-technology-database-annual-reports&amp;data=05%7C01%7CRobert.Reid%40officeforlifesciences.gov.uk%7C52a0f4af72164a3b141608da90ba3996%7Ccbac700502c143ebb497e6492d1b2dd8%7C0%7C0%7C637981426767702174%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=xG98g%2B1%2BBzW72DAM8Cpp8i%2FEn2ic5G1qf2ZbOzZsXXU%3D&amp;reserved=0" target="_blank">Bioscience and health technology sector statistics</a>, this includes analysis of the bio-pharmaceuticals sector of which the medical cannabis industry is an important part.</p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 28/09/2022 09:23:33 answering member 4460 label Biography information for Ms Nusrat Ghani
	tabling member	4488 label Biography information for Martyn Day

1505281

	registered interest
	date	06/09/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to his Department's policy paper entitled Introduction to Sector Deals, updated in June 2019, if he will make an assessment of the potential merits of introducing a sector deal for the medical cannabis industry.
	tabling member constituency	Linlithgow and East Falkirk
	tabling member printed	Martyn Day
	uin	48424
	answer	answer is ministerial correction date of answer 28/09/2022 answer text <p>BEIS have no plans to assess the merits of introducing a sector deal for the medical cannabis industry. We will continue to support the Life Science sector through delivery of the Life Science Vision.</p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 28/09/2022 17:04:30 answering member 4460 label Biography information for Ms Nusrat Ghani
	tabling member	4488 label Biography information for Martyn Day

1521880

	registered interest
	date	13/10/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will make an assessment of the potential economic merits of establishing a British-based medical cannabis industry; and if he will make an assessment of the potential impact of that industry on (a) job creation, (b) research and development and (c) revenue generation.
	tabling member constituency	Tamworth
	tabling member printed	Christopher Pincher
	uin	62806
	answer	answer is ministerial correction date of answer 20/10/2022 answer text <p>The Government have no plans to assess the potential economic merits of establishing a British-based medical cannabis industry. We will continue to support the Life Science sector through delivery of the Life Science Vision.</p> answering member constituency Wealden answering member printed Ms Nusrat Ghani question first answered 20/10/2022 16:09:14 answering member 4460 label Biography information for Ms Nusrat Ghani
	tabling member	4075 label Biography information for Christopher Pincher

1539097

	registered interest
	date	03/11/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, with reference to his Department's policy paper entitled Life Science Vision, published on 6 July 2021, what discussions he has had with representatives of the domestic medical cannabis sector on the speed of uptake of proven products and potential barriers to the spread of new technologies.
	tabling member constituency	Tamworth
	tabling member printed	Christopher Pincher
	uin	78718
	answer	answer is ministerial correction date of answer 11/11/2022 answer text <p>We developed the Life Sciences Vision with wide engagement across the sector, including those involved with a wide range of therapeutic modalities. As part of this we considered carefully matters of regulation, access and uptake of new products – but not specifically with medicinal cannabis producers. We were careful to consider wider work on this issue, including the Taskforce on Innovation, Growth and Regulatory Reform report.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 11/11/2022 14:50:47 answering member 4020 label Biography information for George Freeman
	tabling member	4075 label Biography information for Christopher Pincher

1539390

	registered interest
	date	04/11/2022
	answering body	Department for Business, Energy and Industrial Strategy
	answering dept id	201
	answering dept short name	Business, Energy and Industrial Strategy
	answering dept sort name	Business, Energy and Industrial Strategy
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Business, Energy and Industrial Strategy, pursuant to the Answer of 20 October 2022 to Question 62806 on Cannabis: Medical Treatments, with reference to the Government's Life Sciences Vision, published 6 July 2021, if he will make an assessment of the compatibility of the decision not to assess the potential economic merits of establishing a British-based medical cannabis industry with the UK's aspiration to be the world leader for the development, testing, access and uptake of new and innovative treatments and technologies; and if he will make a statement.
	tabling member constituency	Tamworth
	tabling member printed	Christopher Pincher
	uin	79295
	answer	answer is ministerial correction date of answer 14/11/2022 answer text <p>In developing the UK's Life Science Vision we have conducted wide engagement across the sector, including those involved with a wide range of therapeutic modalities, to understand matters of regulation, access and uptake of new products.</p><p>The Government is confident that it’s broad based strategy, focussed on improving the competitiveness of every aspect of the UK Life Science environment, is the correct approach, and will enhance the UK’s competitiveness across all therapeutic modalities.</p><p>As part of BEIS work on regulation for innovation we are reviewing the TIGRR report and will be continuing delivery plans in due course.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 14/11/2022 17:53:16 answering member 4020 label Biography information for George Freeman
	tabling member	4075 label Biography information for Christopher Pincher

1171346

	registered interest
	date	16/01/2020
	answering body	Department for Digital, Culture, Media and Sport
	answering dept id	10
	answering dept short name	Digital, Culture, Media and Sport
	answering dept sort name	Digital, Culture, Media and Sport
	hansard heading	Cannabis: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether a foundation providing financial support towards private medical cannabis prescriptions for patients where clinically appropriate would be eligible for charitable status; and if she will make a statement.
	tabling member constituency	Hemel Hempstead
	tabling member printed	Sir Mike Penning
	uin	4317
	answer	answer is ministerial correction date of answer 23/01/2020 answer text <p>In England and Wales, an organisation is a charity if it meets a number of legal tests; namely that it is established for exclusively charitable purposes for the public benefit and that it falls within the jurisdiction of the High Court regarding charities. Supporting the cost of medical treatment has long been recognised as capable of being a charitable purpose where the benefit and safety of the treatment can be demonstrated</p><p><br>The Charity Commission, as the independent charity regulator in England and Wales, is responsible for determining whether or not an institution is a charity and for registering those that are and which meet the legal threshold for registration</p><p><br>The Commission robustly assesses each application on its merits against these tests, based on the information provided in the application.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 23/01/2020 16:55:01 answering member 4527 label Biography information for Helen Whately
	tabling member	1528 label Biography information for Sir Mike Penning